New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer

BACKGROUND: Several biomarkers have emerged as potential prognostic and predictive markers for non-small-cell lung cancer (NSCLC). Successful inhibition of angiogenesis with the antivascular endothelial growth factor antibody, bevacizumab, has improved the efficacy seen with standard cytotoxic thera...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Lung Cancer (Auckl)
Main Authors: Niki, Maiko, Yokoi, Takashi, Kurata, Takayasu, Nomura, Shosaku
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2017
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546813/
https://ncbi.nlm.nih.gov/pubmed/28814907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S138887
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker